Diagnostic usefulness of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography in recurrent brain tumor

Journal of Computer Assisted Tomography

Volumn 35, Issue 6, 2011, Pages 679-684

  Hong, Il Ki ^a   Kim, Jeong Hoon ^b   Ra, Young Shin ^b   Kwon, Do Hoon ^b   Oh, Seung Jun ^b   Kim, Jae Seung ^b  

^a Kyung Hee University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

brain neoplasm; diagnosis; FDG; FLT; positron emission tomography; recurrence

Indexed keywords

BRAIN; ELECTRONS; GLUCOSE; MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSITRONS; TUMORS;

2-[F]FLUORO-2-DEOXY-D-GLUCOSE; BRAIN NEOPLASMS; BRAIN TUMORS; FLUORO 2 DEOXY D GLUCOSE; FLUOROTHYMIDINE; GRAY MATTER; RECURRENCE; RECURRENT TUMORS; STANDARDIZED UPTAKE VALUES; WHITE MATTER;

DIAGNOSIS;

3' FLUOROTHYMIDINE F 18;

ADULT; ARTICLE; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GRAY MATTER; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; WHITE MATTER;

EID: 81355132214     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3182345b0e     Document Type: Article

References (28)

1. Graeb DA, Steinbok P, Robertson WD. Transient early computed tomographic changes mimicking tumor progression after brain tumor irradiation. Radiology. 1982;144:813-817. (Pubitemid 12049724)
2. Dooms GC, Hecht S, Brant-Zawadzki M, et al. Brain radiation lesions: MR imaging. Radiology. 1986;158:149-155. (Pubitemid 16172308)
3. Di Chiro G, Oldfield E, Wright DC, et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR Am J Roentgenol. 1988;150:189-197. (Pubitemid 18027033)
4. Glantz MJ, Hoffman JM, Coleman RE, et al. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Ann Neurol. 1991;29:347-355.
5. Burke JW, Podrasky AE, Bradley WG Jr. Meninges: benign postoperative enhancement on MR images. Radiology. 1990;174:99-102. (Pubitemid 20017090)
6. Elster AD, DiPersio DA. Cranial postoperative site: assessment with contrast-enhanced MR imaging. Radiology. 1990;174:93-98. (Pubitemid 20017089)
7. Butowski NA, Sneed PK, Chang SM. Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol. 2006;24:1273-1280. (Pubitemid 46622030)
8. Spence AM, Mankoff DA, Muzi M. Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am. 2003;13:717-739. (Pubitemid 37445051)
9. Meyer MA, Frey KA, Schwaiger M. Discordance between F-18 fluorodeoxyglucose uptake and contrast enhancement in a brain abscess. Clin Nucl Med. 1993;18:682-684. (Pubitemid 23229604)
10. Ricci PE, Karis JP, Heiserman JE, et al. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol. 1998;19:407-413.
11. Sasaki M, Ichiya Y, Kuwabara Y, et al. Ringlike uptake of [18F]FDG in brain abscess: a PET study. J Comput Assist Tomogr. 1990;14:486-487. (Pubitemid 20162584)
12. Chung JK, Kim YK, Kim SK, et al. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2002;29:176-182. (Pubitemid 44763148)
13. Shields AF, Grierson JR, Dohmen BM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med. 1998;4:1334-1336. (Pubitemid 28512118)
14. Rasey JS, Grierson JR, Wiens LW, et al. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med. 2002;43:1210-1217. (Pubitemid 34988769)
15. Chen W, Cloughesy T, Kamdar N, et al. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. J Nucl Med. 2005;46:945-952. (Pubitemid 43733508)
16. 18F]3'-deoxy-3'- fluorothymidine PET for the diagnosis and grading of brain tumors. Eur J Nucl Med Mol Imaging. 2005;32:653-659.
17. Saga T, Kawashima H, Araki N, et al. Evaluation of primary brain tumors with FLT-PET: usefulness and limitations. Clin Nucl Med. 2006;31:774-780. (Pubitemid 44789556)
18. 18F]2-fluoro-2- deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. AJNR Am J Neuroradiol. 1993;14:515-523.
19. Fischman AJ, Thornton AF, Frosch MP, et al. FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma. J Nucl Med. 1997;38:1027-1029. (Pubitemid 27339605)
20. Barker FG, Chang SM, Valk PE, et al. 18F-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer. 1997;79:115-126. (Pubitemid 26425516)
21. Chao ST, Suh JH, Raja S, et al. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer. 2001;96:191-197. (Pubitemid 32520674)
22. Langleben DD, Segall GM. PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med. 2000;41:1861-1867.
23. Hustinx R, Pourdehnad M, Kaschten B, et al. PET imaging for differentiating recurrent brain tumor from radiation necrosis. Radiol Clin North Am. 2005;43:35-47. (Pubitemid 40326558)
24. Ogawa T, Kanno I, Shishido F, et al. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol. 1991;32:197-202.
25. Jacobs AH, Thomas A, Kracht LW, et al. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. J Nucl Med. 2005;46:1948-1958. (Pubitemid 46657440)
26. Rachinger W, Goetz C, Popperl G, et al. Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery. 2005;57:505-511. (Pubitemid 41254459)
27. De Reuck J, Santens P, Goethals P, et al. [Methyl-11C]thymidine positron emission tomography in tumoral and non-tumoral cerebral lesions. Acta Neurol Belg. 1999;99:118-125. (Pubitemid 29320940)
28. Muzi M, Spence AM, OSullivan F, et al. Kinetic analysis of 3′-deoxy-3′-18F-fluorothymidine in patients with gliomas. J Nucl Med. 2006;47:1612-1621. (Pubitemid 47545026)